Aims and Scope
Pediatric Hematology and Oncology is an international peer-reviewed medical journal that covers all aspects of pediatric hematology and oncology. The journal covers immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems.
Key Metrics
2.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
45
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q3
Oncology
SJR
- Q3 Oncology
- Q3 Hematology
- Q3 Pediatrics, Perinatology and Child Health
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.67
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
14%
4 to 6 months
49%
7 to 9 months
30%
Above 9 months
8%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Cancer
- Survival rate
- Sepsis
- Ferritin
- Hepatoblastoma
- Hematopoietic stem cell transplantation
- Pediatric acute myeloid leukemia
- Infantile Fibrosarcoma
- Minimal residual disease
- Dexamethasone
- Anticoagulant
- B-cell acute lymphoblastic leukemia
- Ejection fraction
- Vincristine
- Imatinib
- Septic shock
- Clinical trial
- Hemoglobin
- Rare tumor
- Hemophagocytic lymphohistiocytosis
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Pediatric Hematology and Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial.
- 10 Dec 24
- Pediatric hematology and oncology
-
Full paper
Impact of socioeconomic factors on time to diagnosis of childhood cancer
- 26 Nov 24
- Pediatric Hematology and Oncology
-
Full paper
Current approaches in development and implementation of medical education strategies among pediatric hematology/oncology fellowship programs
- 26 Nov 24
- Pediatric Hematology and Oncology
-
Full paper
Long-Term Survey of Japanese Children with Recurrent Nephroblastoma: A Report from Japan Children’s Cancer Group
- 29 Oct 24
- Pediatric Hematology and Oncology
-
Full paper
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors – But Not for High-Risk Neuroblastoma?
- 23 Oct 24
- Pediatric Hematology and Oncology
-
Full paper
Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers
- 5 Oct 24
- Pediatric Hematology and Oncology
Scite analysis
Powered by scite_
3.2k articles received 25.8k citations see all
- 1,357 Supporting
- 22,938 Mentioning
- 356 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 7 Corrections
- 5 Errata
- 0 Expression of Concern
FAQs
How long has Pediatric Hematology and Oncology been actively publishing?
Pediatric Hematology and Oncology has been in operation since 1986 till date.
What is the publishing frequency of Pediatric Hematology and Oncology ?
Pediatric Hematology and Oncology published with a Bi-monthly frequency.
How many articles did Pediatric Hematology and Oncology publish last years ?
In 2023, Pediatric Hematology and Oncology published 53 articles.
What is the eISSN & pISSN for Pediatric Hematology and Oncology ?
For Pediatric Hematology and Oncology,eISSN is 1521-0669 and pISSN is0888-0018.
What is Citescore for Pediatric Hematology and Oncology ?
Citescore for Pediatric Hematology and Oncology is 2.2.
What is H index for Pediatric Hematology and Oncology ?
H index for Pediatric Hematology and Oncology is 45.
What is SNIP score for Pediatric Hematology and Oncology ?
SNIP score for Pediatric Hematology and Oncology is 0.67.
What is the SJR for Pediatric Hematology and Oncology ?
SJR for Pediatric Hematology and Oncology is Q3.
Who is the publisher of Pediatric Hematology and Oncology ?
TAYLOR & FRANCIS INC is the publisher of Pediatric Hematology and Oncology.